Thomas Hartman Discusses the ISPE Foundation on the Life Science Success Podcast
Thomas Hartman, President and CEO of ISPE and the ISPE Foundation, is interviewed by
![ISPE Foundation](/sites/default/files/styles/site_750_x_420/public/2024-04/Picture1.png?itok=-yxVKLn8)
Thomas Hartman, President and CEO of ISPE and the ISPE Foundation, is interviewed by
The biotechnology industry continues to evolve, advancing the frontiers of science and engineering in the design, development, and manufacture of a wide variety of therapeutic modalities. Advances in cell and gene therapies continue to offer treatments for diseases that were previously uncurable, with seven approvals in 2023, including treatments for sickle-cell disease, hemophilia, type 1...